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ntroduction
Sheep scrapie is a transmissible spongiform encepha-
athy (TSEs); fatal diseases of the central nervous system
S) that also includes Creutzfeldt Jakob Disease (CJD) in
ans, chronic wasting disease in deer and bovine
ngiform encephalopathy (BSE). The principal patholog-
 features of these diseases are neural cell degeneration,
ngiform change and glial cell hypertrophy (Prusiner et
1998) that are linked to the conversion of the normal
cellular prion protein (PrPC, encoded by the PRNP gene) to
the disease-associated conformer PrPSc (Prusiner, 1982).
The central role of PrPC in scrapie is illustrated by the fact
that PRNP knockout mice are resistant to disease (Bueler et
al., 1993) and by the reciprocal relationship between PRNP
copy number and incubation period (Bueler et al., 1993). In
addition, susceptibility to scrapie in sheep is controlled by
PRNP genotype (Goldmann et al., 1994) at codons 136, 154
and 171; in Cheviot sheep ARR/ARR animals are resistant,
VRQ homozygotes have the shortest incubation period and
heterozygotes are intermediate. The cause of the disease is
thought to be linked to replication and accumulation of
PrPSc (Prusiner et al., 1999) and neuronal expression of
PrPC is essential for neurodegeneration and the develop-
ment of disease (Mallucci et al., 2003). However, there are
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A B S T R A C T
Sheep scrapie is a transmissible spongiform encephalopathy (TSE), progressive and fatal
neurodegenerative diseases of the central nervous system (CNS) linked to the accumulation
of misfolded prion protein, PrPSc. New Zealand Cheviot sheep, homozygous for the VRQ
genotype of the PRNP gene are most susceptible with an incubation period of 193 days with
SSBP/1 scrapie. However, the earliest time point that PrPSc can be detected in the CNS is 125
days (D125). The aim of this study was to quantify changes to the transcriptome of the
thalamus and obex (medulla) at times immediately before (D75) and after (D125) PrPSc was
detected. Affymetrix gene arrays were used to quantify gene expression in the thalamus and
Illumina DGE-tag proﬁling for obex. Ingenuity Pathway Analysis was used to help describe
the biological processes of scrapie pathology.
Neurological disease and Cancer were common Bio Functions in each tissue at D75;
inﬂammation and cell death were major processes at D125. Several neurological receptors
were signiﬁcantly increased at D75 (e.g. CHRNA6, GRM1, HCN2), which might be clues to
the molecular basis of psychiatric changes associated with TSEs. No genes were
signiﬁcantly differentially expressed at both D75 and D125 and there was no progression
of events from earlier to later time points. This implies that there is no simple linear
progression of pathological or molecular events. There seems to be a step-change between
D75 and D125, correlating with the detection of PrPSc, resulting in the involvement of
different pathological processes in later TSE disease.
 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC
BY license (http://creativecommons.org/licenses/by/3.0/).
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the CNS and disease. In some scrapie strain/host combina-
tions high titres of infectivity are associated with low levels
of PrPSc (Barron et al., 2007); in others the accumulation of
PrPSc in the brain is not associated with transmissible
disease (Piccardo et al., 2013). This lack of direct
correlation between quantitative levels of PrPSc aggrega-
tion and infectivity raises two major questions. The ﬁrst is
the fundamental question of how scrapie agent/PrPSc
causes cell pathology and disease and secondly, are there
surrogate markers of infectivity and disease other than
PrPSc.
An understanding of the disease-causing mechanisms
of TSE agents is critical for the selection of potential
therapeutic targets. In recent years there have been a
number of functional genomic studies with the aim of
quantifying differential gene expression in the CNS
and the consequent identiﬁcation of molecular
pathways associated with the progression of TSE disease.
Most of these studies have used mouse models of
scrapie (Skinner et al., 2006; Xiang et al., 2004) but more
recently BSE and scrapie from orally-infected cattle
(Almeida et al., 2011a) and sheep (Filali et al., 2012),
and human CJD (Tian et al., 2013) have been examined.
Perhaps the most comprehensive analysis was described
by Hwang (Hwang et al., 2009) who compared eight
combinations of mice and scrapie strains at different
time points after infection and identiﬁed a panel of
differentially-expressed genes central to TSE disease. In
addition, similar technologies have been used to try and
identify potential alternative markers of TSE infection
(Sorensen et al., 2008). The use of a diverse range of
species and TSE agents and time points has resulted in a
large range of genes and pathways being identiﬁed.
However, there have been a number of physiological
pathways consistently linked to progression of TSE
disease in the CNS, including the up-regulation of genes
involved in inﬂammation (Xiang et al., 2004), immune
response (Sorensen et al., 2008), autophagy and cell
death (Brown et al., 2005) as well as regulation of
transcription (Skinner et al., 2006).
Previous studies from this laboratory used the SSBP/1
sheep scrapie model in New Zealand sheep to describe
the progression of pathology, as indicated by the
detection of PrPSc, in different regions of the brain
(Gossner et al., 2011a) and peripheral lymphoid tissues
(Gossner et al., 2011b), in sheep with deﬁned PRNP
genotypes. The earliest time that PrPSc was detected by
immunohistochemistry in the thalamus and obex was
125 days (D125) after subcutaneous inoculation of SSBP/
1 in VRQ homozygous animals; terminal disease was
193  12 days. This current study exploits these same
sheep to quantify the effects of scrapie infection on the
transcriptome of the thalamus and obex immediately
before (D75) and at the time point when PrPSc is
consistently detected in the CNS. For these studies we
use the new Affymetrix Ovine Gene 1.1 ST whole-genome
arrays validated by Illumina digital gene expression-tag
proﬁling (DGS-tag). In this way we examine scrapie
infection of the brain and begin to uncouple the effects
of infection from the effects of PrPSc accumulation.
2. Materials and methods
2.1. Animals and experimental design
Details of sheep, infection regime and tissues have been
described previously (Gossner et al., 2011a). Brieﬂy, New
Zealand Cheviot sheep homozygous for the PRNP genotype
VRQ (Houston et al., 2002), were infected subcutaneously
in shoulder with SSBP/1 sheep brain homogenate or
scrapie-negative brain homogenate. Sheep were in groups
of ﬁve, 3 scrapie-infected and two uninfected controls and
were sacriﬁced at 75 days (D75) and 125 days (D125) post
infection. Animal experiments were approved by BBSRC
Institute for Animal Health Ethical Review Committee and
conducted under an Animals (Scientiﬁc Procedures) Act
1986 Project Licence.
2.2. Tissue collection and RNA isolation
Tissues were removed immediately post-mortem, and
5 mm3 blocks incubated overnight at 4 8C in RNALater
(Ambion, Huntingdon, UK) and stored at 80 8C. Total RNA
was isolated using RNeasy Lipid Tissue Mini Kit (Qiagen,
Crawley, UK) with DNase I digestion. RNA integrity and
quality was assessed by a RNA 6000 Nano LabChip on the
Agilent 2100 Bioanalyzer and quantiﬁed using the
NanoDrop ND-1000 spectrophotometer.
2.3. RNA and microarray processing
Sense-strand cDNA from 0.5 mg RNA was ampliﬁed
using two rounds of the Ambion1 WT Expression Kit.
Ampliﬁed cDNA was biotin labelled and fragmented
using the Affymetrix GeneChip1 WT Terminal Labelling
and Hybridization kit. Labelled cDNA fragments (5.5 mg)
were hybridized to Affymetrix Ovine Gene 1.1 ST arrays
using the Hyb-Wash-Scan procedure using reagents from
the Affymetrix Gene Titan Hyb Wash Stain kit. Plates
were then washed, stained and scanned using the
Imaging Station of the GeneTitan System. The Affyme-
trix1 GeneChip1 Command Console1 Software v 3.0.1
was used to generate array images and the Affymetrix
CEL ﬁles. QC was performed using Affymetrix Expression
Console.
2.4. Array data analysis
The CEL ﬁles were imported into Partek Genomics Suite
v 6 (http://www.partek.com/?q=partekgs) and data were
analysed at the gene-level, with exons summarized to
genes, using the mean expression of all exons of a gene.
Background correction used the robust multiarray average
(RMA) algorithm, with quantile normalization, median
polish probe summarization, and log2 prob-e transforma-
tion. Differentially expressed genes were identiﬁed by
analysis of variance and the q value, a measure of the
proportion of false positives incurred – the false discovery
rate, was used as measure of statistical signiﬁcance (Storey
and Tibshirani, 2003). Hierarchical clustering was per-
formed on signiﬁcant genes, with the data normalized to a
mean of zero and scaled to standard deviation of one using
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ed on similarity scores in BLASTN comparisons of
metrix Transcript cluster sequences against ovine/
ine sequences in GenBank. Detailed protocols and all
 data are available at the ArrayExpress database
w.ebi.ac.uk/arrayexpress) under accession number
TAB-2385.
 Illumina digital gene expression (DGE) tag-proﬁling
Sequence tag libraries were constructed using the
mina DGE Tag Proﬁling NlaIII Sample Prep kit according
he manufacturer’s protocol. In brief, mRNA was isolated
 2 mg of total RNA using Oligo dT beads. First- and
ond-strand cDNA were synthesized while the mRNA
s attached to the beads. Subsequently, cDNA samples
re digested using NlaIII, which recognizes and cuts the
st 30 ‘CATG’ motif. GEX NlaIII Adapter 1 was ligated at
 site of NlaIII cleavage. The GEX Adapter 2 was ligated
r MmeI digestion. The adapter-ligated cDNA tags were
iched using PCR, and puriﬁed on PAGE gel. The puriﬁed
A tags were used to create clusters on a ﬂow cell using
Illumina Cluster Station and were sequenced on an
mina Genome Analyser II instrument. Image recogni-
 and base calling were performed using the Illumina
eline.
 Mapping and analysis of genes identiﬁed by DGE-tag
ﬁling
Processed sequence ﬁles from the Illumina pipeline
put were aligned against version 3.1 assembly of the
s aries genome (http://www.ncbi.nlm.nih.gov/geno-
?term=ovis%20aries) with the short read aligner Bowtie
ngmead and Salzberg, 2012). The mapped reads were
embled and annotated into transcript level expression
maries of count data from each sample using the
rsectBed utility from the BEDTools suite (Quinlan and
l, 2010) and sheep transcript sequences (http://
w.livestockgenomics.csiro.au/sheep/oarv3/Oarv3.1.-
tein.gene.gff3). The summarized data was ﬁltered and
le normalized before converting the read counts to log2-
, with associated weights, using the Voom (http://
w.statsci.org/smyth/pubs/VoomPreprint.pdf) routine
imma part of Bioconductor R (http://bioconductor.org).
tistical analysis was performed using the eBayes
ction after the log-normalized counts were used to
struct a linear model and ﬁnd differentially expressed
) genes between SSBP/1 infected and control samples.
 Functional enrichment and network analysis
Network analysis was performed with Ingenuity
hway Analysis software (http://www.ingenuity.com/)
ncrease conﬁdence in the observations of differentially
ressed genes by correlation with biological pathways.
s process also allowed the identiﬁcation of putative key
ctional elements within the networks of differentially
ressed genes. The network interaction of the focused
es in the network is based on their connectivity in
enuity Knowledge Base.
3. Results
3.1. Differential gene expression at D75 and D125
Affymetrix arrays identiﬁed 337 signiﬁcantly differen-
tially-expressed genes with fold change 1.5 and adjusted
p value (q value)  0.05 at D75 after SSBP/1 infection, prior
to the immunohistochemical detection of PrPSc (Gossner
et al., 2011a) in the thalamus (Table S1), in comparison to
uninfected controls (C); 163 genes were signiﬁcantly
increased and 174 were repressed. At D125, the ﬁrst time
point when PrPSc was detected in the thalamus, 243 genes
were signiﬁcantly differentially-expressed, with 162 genes
increased and 81 repressed (Table S2). No genes were
common in the two comparisons D75 vs. C and D125 vs. C;
neither were there any signiﬁcantly expressed genes in the
direct comparison of the two infected groups, D75 vs.
D125. Presentation of these data by heat map (Fig. S1)
illustrates the consistency of the data from the individual
sheep within the infected and control groups.
The most up-regulated genes in the infected thalamus
(Table 1) included CHRNA3 (+5.81 fold), MET (+3.81 fold)
and MEIS2 (+2.99 fold) at D75; and PARP3 (+3.17 fold) and
CAMP (+2.50 fold) at D125. The most repressed included HP
(5.22 fold) and AVP (6.59 fold) both q  0.0497; and
CD3E (4.62 fold), CCR7 (5.65 fold) and IGHV4-61 (9.82
fold) at D125. The array data were also analysed in relation
to fold change but without regard to p value (Table S3)
helping to conﬁrm the data in Table 1 and Tables S1 and S2.
The top-ranked gene at D75 was also a neuronal
cholinergic receptor, (CHRNA2, +7.43 fold, p = 0.1689);
CHRNA5 was also increased 3.09 fold (p = 0.0755) at this
D75 time point. Many of the most repressed genes at D125
(but q > 0.05) are associated with lymphocyte function.
The B cell receptor gene CD72A was decreased (+3.06 fold,
p = 0.0917) as were the immunoglobulin heavy chain
genes, IGHE (7.93 fold, p = 0.1142), IGHA2 (6.14 fold,
p = 0.0922), IGM (5.97, p = 0.0744) and both light chain
genes, IGK (4.24, p = 0.1346) and IGL (3.85, p = 0.0576).
Genes associated with the T cell receptor/CD3 complex
were also repressed, including TRB 2.43 fold, p = 0.2296),
CD3D (4.39 fold, p = 0.0869) and CD3G (2.97 fold,
p = 0.1245). Raw data as well as detailed protocols of the
experimental procedures, methods of analysis and array
data are available as supplementary information in the
ArrayExpress database (www.ebi.ac.uk/arrayexpress) un-
der accession numbers E-MTAB-2369 (array) and E-MTAB-
2385 (DEG-tag).
3.2. Ingenuity pathway analysis
Ingenuity pathway analysis (IPA) was used to help
describe how differentially-expressed genes inﬂuence the
biological processes leading to the development of CNS
pathology in the SSBP/1 model of sheep scrapie. The
Affymetrix ovine gene arrays identiﬁed eight networks
(P-scores < 26) in the D75 and D125 vs. C comparisons
(Table 2). The two top-ranked networks were ‘Hereditary
disorder, metabolic disease, cancer’ at D75 and ‘Dermato-
logical diseases and conditions, developmental disorder,
organismal injury and abnormalities’ at D125, both with
A.G. Gossner, J. Hopkins / Veterinary Microbiology 173 (2014) 201–207204P-scores of 37. The top Bio Functions within these
networks at D75 (Table 3) were ‘Neurological disease’
with 47 genes with the highest p value of 1.37  106 and
‘Cancer’ with 72 genes 5.06  106 associated with
Diseases and Disorders, and ‘Cell morphology’ with 25
genes p = 4.52  107 (Molecular and cellular functions).
Also notable were ‘Psychological disorders’ with 28 genes
p = 3.41  105 (Diseases and disorders) and ‘Cell death
and survival’ with 42 genes p = 2.58  106 (Molecular and
cellular functions).
At D125 top Bio Functions include (Table 3) ‘Immuno-
logical disease’ with 17 genes p = 3.10  104 (Diseases and
Disorders) and ‘Cell death and survival’ with 22 genes
p = 3.52  106 (Molecular and cellular functions). Also
notable were ‘Inﬂammatory response’ with 16 genes
p = 2.36  104, and ‘Cancer’ with 20 genes p = 4.02  104
(Diseases and disorders) and ‘Cell growth and proliferation’
with 22 genes p = 3.85  106 (Molecular and cellular
functions). The identity of the genes associated with the
Bio Functions is shown in Table S4A).
3.3. DGE-tag proﬁling
Illumina Solexa DGE-tag proﬁling was performed on the
obex (medulla) of the same animals as used for the
Affymetrix arrays and delivered a mean of 7,157,973 mer
tags per sample (min 3,795,081; max 14,460,672); of
Table 1
Top ﬁve up- and down-regulated genes at D75 and at D125.
Transcript Gene symbol Accession no Gene name q Value FC
Genes signiﬁcant at D75
14817287 CHRNA3 XM_004017821.1 Cholinergic receptor, nicotinic, alpha 3 0.0497 5.81
14727871 HAPLN4 XM_004009142.1 Hyaluronan and proteoglycan link protein 4 0.0497 4.28
14721176 MET NM_001111071.1 met Proto-oncogene 0.0497 3.81
14739337 MALRD1 XM_005890186.1 MAM and LDL rec class A domain containing 1 0.0497 3.38
14723057 MEIS2 XM_004023192.1 Meis homeobox 2 0.0497 2.99
14714901 HP XM_004015111.1 Haptoglobin 0.0497 5.22
14841329 SIM1 XM_004011247.1 Single-minded homolog 1 0.0497 5.23
14819176 GRP NM_001009321.1 Gastrin-releasing peptide 0.0497 5.68
14861184 FOXB2 XM_002689669.2 Forkhead box B2 0.0497 6.00
14894315 AVP NM_001126341.1 Arginine vasopressin 0.0497 6.59
Genes signiﬁcant at D125
14795740 PARP3 XM_004018417.1 Poly (ADP-ribose) polymerase family, member 3 0.0498 3.17
14716666 CLHC1 XM_004005946.1 Clathrin heavy chain linker domain containing 0.0429 2.98
14766190 CAMP U60598.1 Cathelicidin antimicrobial peptide 0.0459 2.50
14848532 FZD7 XM_004005406.1 Frizzled family receptor 7 0.0474 2.48
14817394 PPOX XR_173400.1 Protoporphyrinogen oxidase 0.0459 2.44
14781091 HLA-A XR_173400.1 Major histocompatibility complex, class I, A 0.0474 4.44
14715765 CD3E NM_001009418.2 CD3e molecule, epsilon (CD3-TCR complex) 0.0498 4.62
14795357 HIST1H1B XM_605694.3 Histone cluster 1, H1b 0.0498 5.37
14757190 CCR7 XM_004012868.1 Chemokine (C–C motif) receptor 7 0.0498 5.65
14814506 IGHV4-61 AJ505116.1 Immunoglobulin heavy variable 4–61 0.0498 9.82
The ﬁve most up- and down-regulated genes based on fold change (q  0.05) in SSBP/1-infected thalamus at D75 and at D125 as assessed by Affymetrix
whole genome array.
Table 2
Top networks identiﬁed by Ingenuity Pathway Analysis from Affymetrix
whole genome array.
Thalamus D75 vs. C P-score
Hereditary disorder, metabolic disease, cancer 37
Cellular movement, molecular transport, cancer 32
Cell cycle, auditory disease, auditory and
vestibular system development and function
31
Drug metabolism, small molecule biochemistry,
organismal injury
and abnormalities
27
Cell-to-cell signaling and interaction,
hematological system development
and function, humoral immune response
26
Thalamus D125 vs. C P-score
Dermatological diseases and conditions,
developmental disorder, organismal
injury and abnormalities
37
Cell morphology, hematological system
development and function, cell-mediated
immune response
35
Cell-to-cell signaling and interaction, 26
Table 3
Top Bio Functions identiﬁed by IPA from Affymetrix whole genome array.
P-value No of
molecules
D75 vs. C
Diseases and disorders
Neurological disease 1.37E-06–1.19-02 47
Cancer 5.06E-06–1.19-02 72
Psychological disorders 3.41E-05–1.13-02 28
Molecular and cellular functions
Cell morphology 4.52E-07–1.19-02 25
Cellular function and
maintenance
4.52E-07–1.19-02 38
Cell death and survival 2.58E-06–1.19-02 42
D125 vs. C
Diseases and disorders
Immunological disease 3.10E-04–3.53E-02 17
Inﬂammatory response 2.36E-04–4.29E-02 16
Cancer 4.02E-04–4.33E-02 20
Molecular and cellular functions
Cell death and survival 3.53E-06–3.02E-02 22
Cell growth and proliferation 3.85E-06–4.00E-02 22cellular growth and proliferation, cell morphology Cell morphology 5.16E-06–4.00E-02 14
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re selected on the basis of log-odds that the gene is
erentially expressed, or B-statistic (Smyth, 2004). The
 500 genes for each tissue in the obex are shown in
le S5. At D75, before PrPSc could be detected in the obex
ssner et al., 2011a), 278 genes were increased and 223
ressed. D125 was earliest time point that PrPSc was
ected, and 222 were increased and 278 repressed. Of
 500 genes in each comparison, 360 genes (203
reased and 157 repressed) with p  0.05 and 206 with
 0.05 at D75; at D125 there were 311 (138 increased
 173 repressed) with p  0.05 but none with q  0.05,
 lowest q value was 0.0786.
IPA analysis of the DGE-tag dataset for the two time
nts for the obex is shown in Table 4. Comparison of this
lysis with the IPA from the Affymetrix array data for the
lamus at D75 (Table 3) identiﬁed the ‘Cancer’ Bio-
ction in common in Diseases and Disorders, and ‘Cell
vement’ and ‘Cellular function and maintenance’ in
lecular and Cellular Functions. At D125 ‘Cancer’ is also a
mon Bio-Function in Diseases and Disorders; and in
lecular and Cellular Functions all three Bio-Functions
 common to both analyses, ‘Cell Death and Survival’,
ll Morphology’ and ‘Cell Growth and Proliferation’. The
ntity of the genes associated with the Bio Functions is
wn in Table S4B.
iscussion
This project is a development of a previous RT-qPCR
dy on the expression of selected genes in different
ions of the CNS during the time course of SSBP/1 scrapie
ction (Gossner et al., 2011a), and aims to detail
nges in the transcriptome before, and immediately
r the detection of PrPSc in the thalamus and obex
(medulla) regions of the CNS. The thalamus and obex are
both sites of scrapie pathology (Gonza´lez et al., 2003) and
PrPSc aggregation can be detected for the ﬁrst time in both
tissues at D125 (Gossner et al., 2011a). Transcriptome
analysis of the thalamus was by the Affymetrix Ovine gene
1.1 ST Array, which consists of probes for all exons in each
annotated transcript of the OARv2 sheep genome assem-
bly. Analysis of the obex was by DGE-tag proﬁling, which
provides a more complete coverage of the transcriptome
than selected RT-qPCR assays. DGE-tag proﬁling of obex
identiﬁed similar numbers of differentially-expressed
genes (p  0.05) as the array, with approximately equiva-
lent proportions increased and repressed. However, the
array data permitted more accurate annotation than DGE-
tag proﬁling because the tags were only 21 base sequences.
The initial RT-qPCR and DGE-proﬁling exhausted the
supply of obex and consequently the thalamus was used
for the arrays. Nevertheless, comparable and/or identical
IPA bio-functions were identiﬁed by both technologies in
both tissues.
In view of the fact that the major target organ for TSEs is
the brain the majority of gene expression studies on the
progression of disease have focussed on the CNS; most of
these have used time course analyses in mouse models of
scrapie (Skinner et al., 2006; Xiang et al., 2004). A
difference between these time course studies in mice and
this study is that SSBP/1 sheep scrapie does not show a
simple linear progression, but rather a step-wise change
from D75 to D125, relating to the times when PrPSc can be
detected by immunohistochemistry.
All the mouse studies identiﬁed a large range of
differentially-expressed genes, but most showed consis-
tent reduction in the genes associated with cholesterol
metabolism and promoting complement ﬁxation, inﬂam-
mation and cell death/apoptosis. A large, multi-component
study using two mouse-adapted scrapie strains infecting
ﬁve mouse strains over several time points, identiﬁed a
core set of 333 genes that appear central to prion disease
(Hwang et al., 2009). It also identiﬁed similar physiological
networks to the previous studies. Our study identiﬁed 33
of this core set that were differentially-expressed, includ-
ing CXCR4, S100A11 and NCF3 at D75 and VCAM1, XCL1 and
ADAM4 at D125. The current study also highlights
inﬂammation and apoptosis/cell death as signiﬁcant
components of TSE pathogenesis, although this is particu-
larly true at the D125 time point (e.g. CAMP +2.5 fold and
TRADD +1.77 fold). However, a major difference is that
there seems to be no reduction in cholesterol metabolism
genes in the sheep study. A possible reason for this could be
one of species difference as studies of bovine BSE (Almeida
et al., 2011b) also fail to identify a reduction in cholesterol
associated genes.
Two of the major pathological features of TSEs are
microglial activation and astrocyte proliferation (Rezaie
and Lantos, 2001), and this may explain that Ingenuity
Pathway Analysis for both the array and DGE-tag datasets
highlights Bio Functions associated with inﬂammation,
immunity and cancer. Inﬂammatory inﬁltration and
polymorphonuclear cell cufﬁng in the blood vessels of
the brain are not features of TSE disease (Porter et al.,
1973). Indeed, the data reported here indicate a marked
le 4
 Bio Functions at D75 and D125 identiﬁed by IPA from DGE-tag
ysis.
P-value No of
molecules
5 vs. C
Diseases and disorders
Cancer 6.83E-06–2.23E-02 110
Organismal injury and
abnormalities
7.89E-05–2.23E-02 29
Neurological disease 4.06E-04–2.03E-02 69
Molecular and cellular functions
Cellular movement 1.58E-04–1.90E-02 22
Cell assembly and
organization
2.56E-04–2.07E-02 38
Cellular function and
maintenance
6.25E-04–1.99E-02 36
25 vs. C
Diseases and disorders
Cancer 7.35E-06–1.43E-02 193
Neurological disease 4.04E-04–1.43E-02 42
Organismal injury and
abnormalities
5.83E-04–1.43E-02 54
Molecular and cellular functions
Cell death and survival 9.70E-05–1.43E-02 88
Cell morphology 1.72E-04–1.43E-02 61
Cell growth and
proliferation
2.04E-04–1.43E-02 39
A.G. Gossner, J. Hopkins / Veterinary Microbiology 173 (2014) 201–207206reduction in lymphocyte inﬁltration into the diseased
brain, especially at D125, illustrated by repression of
many genes associated with both lymphocyte popula-
tions, including B cell (e.g. IGHV, CD79A) and T cell
receptor complexes (e.g. TRA, CD3E). There is also
signiﬁcant repression of XCL1 and CCR7 (and CCL21,
p > 0.05), chemokine/receptors that control lymphocyte
but not myeloid cell migration (Rot and von Andrian,
2004). The increase in inﬂammatory gene expression was
seen largely at D125 after the detection of PrPSc; this is
consistent with other studies that describe the produc-
tion of inﬂammatory mediators by glia (Peyrin et al.,
1999), possibly activated by fragments of PrPSc (Rezaie
and Lantos, 2001).
The other major pathological feature of all TSEs is
neurodegeneration, and the ‘Neurological disease’ Bio
Function is identiﬁed in the thalamus at D75 and in the
obex at both D75 and D125. Two highly repressed genes
within this Bio Function play major roles in the regulation
of blood pressure; AGTR1 (4.57 fold) and AVP (6.59 fold)
are both vasoconstrictors and low expression levels in the
brain reduces blood supply (Matsusaka and Ichikawa,
1997) leading to impaired memory and cognition as well as
social dysfunction (Bielsky et al., 2004). Furthermore,
modiﬁcations to the interactions between arginine vaso-
pressin (AVP) and its receptor results in subtle olfactory
deﬁcits, evidenced by 6 olfactory genes signiﬁcantly
increased (e.g. OR6C4 +2.03 fold) and 8 repressed (e.g.
OR8B3 1.80 fold) at D75, and 18 genes signiﬁcantly
increased and 2 repressed at D125.
The nicotinic acetylcholine receptor family proteins
are ion-channels that play a role in neurotransmission
and are linked to nicotine and alcohol dependence (Exley
et al., 2011). In the CNS they are expressed by the
dopaminergic neurons and differential expression can
lead to anxiety and neuroses followed by depression
(Hogg et al., 2003). In this study CHRNA3 and CHRNA6 are
signiﬁcantly raised at D75 (+5.81 and +2.47 fold); and
three other members of the family are non-signiﬁcantly
increased, CHRNA2 (+7.47 fold), CHRNA4 (+2.04 fold) and
CHRNA5 (+3.09 fold). No acetylcholine receptors are
signiﬁcantly differentially-expressed at D125 but
CHRNA2 (2.99 fold) and CHRNA3 (2.40 fold) are
repressed but p > 0.05. Two other neuronal receptors
are also differentially expressed at D75. GRM1 is
associated with a number of neurological diseases
including schizophrenia and depression (Kohara et al.,
2008) and is signiﬁcantly increased +1.83 fold, and HCN2,
which contributes to spontaneous brain rhythmic activi-
ty, and dysfunction is associated with epilepsy (Bender
et al., 2003), is increased +2.7 fold. These data imply that
alterations in expression of these genes may play a role in
the psychiatric changes associated with TSEs.
In conclusion, SSBP/1 sheep scrapie infection in its
natural host identiﬁes changes to the transcriptome of
the thalamus and obex at times immediately before
and after the detection of the disease-associated form
of the prion protein, PrPSc. The analysis identiﬁes some of
the molecular mechanisms associated with TSE disease in
sheep and highlights: inﬂammation, possibly linked to
survival possibly associated with neurodegeneration;
and cancer, possible linked to gliosis. In addition,
the identity of some of the genes within the ‘Neurological
disease’ Bio Function may give clues to the basis of
TSE-associated psychiatric problems. However,
there seems to be no relationship and little progression
of quantitative gene changes, from before (D75) to after
the detection of PrPSc (D125). These data imply that
SSBP/1 sheep scrapie is not a simple linear progression
from infection to death, but that the eventual accumula-
tion of disease-associated PrPSc triggers a step change in
CNS and consequently a change in the pathological
process.
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